Protara Therapeutics, Inc.

Protara Therapeutics, Inc. - PE Ratioverified

TARA

Price:

$3.98

Market Cap:

$153.59M

Protara Therapeutics, Inc. is a biotechnology company actively involved in clinical research and development, striving to identify and advance groundbreaking therapies. Their core mission is to tackle significant medical challenges in both oncology and rare disease domains. The company's leading therapeutic candidate, TARA-002, is an investigational cellular therapy currently under evaluation for the treatment of lymphatic malformations. Furthermore, Protara is developing intravenous choline chloride, a potential phospholipid substrate replacement therapy aimed at addressing liver disease associated with intestinal failure. The organization, which was formerly known as ArTara Therapeutics, I...[Read more]

Industry

Biotechnology

IPO Date

2014-10-22

Stock Exchange

NASDAQ

Ticker

TARA

The PE Ratio as of June 2026 (TTM) for Protara Therapeutics, Inc. (TARA) is -2.93

According to Protara Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -2.93. This represents a change of -4.56% compared to the average of -3.07 of the last 4 quarters.

Protara Therapeutics, Inc. (TARA) Historical PE Ratio (quarterly & annually)

How has TARA PE Ratio performed in the past?

The mean historical PE Ratio of Protara Therapeutics, Inc. over the last ten years is -3.00. The current -2.93 PE Ratio has changed 9.66% with respect to the historical average. Over the past ten years (40 quarters), TARA's PE Ratio was at its highest in in the December 2022 quarter at -0.19. The PE Ratio was at its lowest in in the December 2018 quarter at -42.04.

Quarterly (TTM)
Annual

Average

-3.00

Median

-2.02

Minimum

-9.14

Maximum

-0.46

Protara Therapeutics, Inc. (TARA) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Protara Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 734.75%

Maximum Annual PE Ratio = -0.46

Minimum Annual Increase = -90.77%

Minimum Annual PE Ratio = -9.14

Quarterly (TTM)
Annual
YearPE RatioChange
2025-3.9863.47%
2024-2.43362.05%
2023-0.5315.15%
2022-0.46-71.54%
2021-1.61-68.80%
2020-5.1514.01%
2019-4.52-50.59%
2018-9.14734.75%
2017-1.10-0.69%
2016-1.10-90.77%

Protara Therapeutics, Inc. (TARA) Average PE Ratio

How has TARA PE Ratio performed in the past?

The current PE Ratio of Protara Therapeutics, Inc. (TARA) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

3-year avg

-2.31

5-year avg

-1.80

10-year avg

-3.00

Protara Therapeutics, Inc. (TARA) PE Ratio vs. Peers

How is TARA’s PE Ratio compared to its peers?

Protara Therapeutics, Inc.’s PE Ratio is less than Neonc Technologies Holdings, Inc. (-2.72), greater than Genfit S.A. (-6.20), less than Invivyd, Inc. (-2.59), greater than Codexis, Inc. (-7.02), greater than MediWound Ltd. (-6.30), greater than SELLAS Life Sciences Group, Inc. (-35.26), greater than OmniAb, Inc. (-5.09), less than Orchestra BioMed Holdings, Inc. (-2.81), less than Sangamo Therapeutics, Inc. (-0.45), greater than Prelude Therapeutics Incorporated (-4.08),

Build a custom stock screener for Protara Therapeutics, Inc. (TARA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Protara Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Protara Therapeutics, Inc. (TARA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Protara Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Protara Therapeutics, Inc.'s PE Ratio?

How is the PE Ratio calculated for Protara Therapeutics, Inc. (TARA)?

What is the highest PE Ratio for Protara Therapeutics, Inc. (TARA)?

What is the 3-year average PE Ratio for Protara Therapeutics, Inc. (TARA)?

What is the 5-year average PE Ratio for Protara Therapeutics, Inc. (TARA)?

How does the current PE Ratio for Protara Therapeutics, Inc. (TARA) compare to its historical average?